Back to Search
Start Over
Insmed price target raised by $8 at Wells Fargo, here's why
- Source :
- The Fly. August 9, 2024
- Publication Year :
- 2024
-
Abstract
- Wells Fargo analyst Tiago Fauth raised the firm's price target on Insmed to $85 from $77 and keeps an Overweight rating on the shares. The firm thinks Treprostinil Palmitil Inhalation [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.804340178